BREAKING: The Professional Fighters League (PFL) has suspended featherweight champion Movlid Khaybulaev for one year after testing positive for a banned substance. The announcement was made just moments ago, sending shockwaves through the MMA community.
This urgent development comes after Khaybulaev’s victory against Jesus Pinedo in the finals of the 2025 PFL World Tournament on August 1, 2025, where he secured a fifth-round submission win. However, his in-competition sample, collected on the same day, tested positive for recombinant erythropoietin, a substance that enhances athletic performance.
The suspension will be retroactive to the date of the positive test, meaning Khaybulaev will be sidelined until at least August 1, 2026. This ruling not only disqualifies him from the tournament but also strips him of his championship title, belt, and any associated bonuses.
According to the PFL, “Pursuant to PFL rules and regulations, Khaybulaev has been disqualified from the 2025 PFL World Tournament.” This decision follows the recent end of the PFL’s partnership with the United States Anti-Doping Agency (USADA), which had been overseeing their drug testing program. The PFL has now transitioned to working with the Mohegan Sun Tribe Department of Athletic Regulation for future drug testing efforts.
This incident raises significant questions about athlete safety and the integrity of competitive sports. Fans and fellow fighters alike are expressing their disappointment and concern over the implications of performance-enhancing drugs in the sport.
With Khaybulaev’s suspension, the PFL faces a critical moment as it navigates its new drug testing protocols. The organization aims to maintain the integrity of the sport while ensuring that athletes compete on a level playing field.
As the situation develops, all eyes will be on the PFL and how they handle the aftermath of this high-profile case. Further updates are expected soon, and the MMA community is watching closely.
